Dr. Richard Gralla, MD

NPI: 1710167002
Total Payments
$351,325
2024 Payments
$13,744
Companies
12
Transactions
134

Payment Breakdown by Category

Other$132,634 (37.8%)
Travel$126,652 (36.0%)
Consulting$90,238 (25.7%)
Food & Beverage$1,801 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $126,652 61 36.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $103,312 12 29.4%
Consulting Fee $90,238 20 25.7%
Honoraria $29,322 2 8.3%
Food and Beverage $1,801 39 0.5%

Top Paying Companies

Company Total Records Latest Year
Helsinn Healthcare SA $165,837 56 $0 (2024)
Merck Sharp & Dohme Corporation $88,718 19 $0 (2018)
Purdue Pharma $43,687 4 $0 (2019)
Vifor (International) Ltd. $18,001 4 $0 (2019)
Eli Lilly and Company $11,766 30 $0 (2020)
Helsinn Therapeutics (U.S.), Inc. $6,561 8 $0 (2017)
Bayer HealthCare Pharmaceuticals Inc. $6,073 2 $0 (2022)
PFIZER INC. $4,863 2 $0 (2017)
Taiho Oncology, Inc. $2,994 5 $0 (2017)
Heron Therapeutics, Inc. $2,123 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $13,744 2 Helsinn Healthcare SA ($13,744)
2023 $14,611 5 Helsinn Healthcare SA ($14,611)
2022 $23,696 7 Helsinn Healthcare SA ($17,664)
2021 $5,700 2 Helsinn Healthcare SA ($5,700)
2020 $16,251 32 Eli Lilly and Company ($11,766)
2019 $85,183 27 Helsinn Healthcare SA ($44,879)
2018 $85,782 20 Helsinn Healthcare SA ($35,323)
2017 $106,358 39 Merck Sharp & Dohme Corporation ($60,307)

All Payment Transactions

134 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/04/2024 Helsinn Healthcare SA Consulting Fee Cash or cash equivalent $6,600.00 General
05/01/2024 Helsinn Healthcare SA Travel and Lodging In-kind items and services $7,144.44 General
08/03/2023 Helsinn Healthcare SA Travel and Lodging In-kind items and services $8,214.72 General
08/03/2023 Helsinn Healthcare SA Consulting Fee Cash or cash equivalent $6,000.00 General
08/03/2023 Helsinn Healthcare SA Travel and Lodging In-kind items and services $165.20 General
08/03/2023 Helsinn Healthcare SA Food and Beverage In-kind items and services $154.00 General
08/03/2023 Helsinn Healthcare SA Food and Beverage In-kind items and services $77.00 General
10/15/2022 Helsinn Healthcare SA AKYNZEO (Drug) Travel and Lodging In-kind items and services $9,135.84 General
Category: ONCOLOGY
10/15/2022 Helsinn Healthcare SA AKYNZEO (Drug) Consulting Fee Cash or cash equivalent $8,000.00 General
Category: ONCOLOGY
10/15/2022 Helsinn Healthcare SA AKYNZEO (Drug) Travel and Lodging In-kind items and services $286.30 General
Category: ONCOLOGY
10/15/2022 Helsinn Healthcare SA AKYNZEO (Drug) Travel and Lodging In-kind items and services $98.83 General
Category: ONCOLOGY
10/15/2022 Helsinn Healthcare SA AKYNZEO (Drug) Food and Beverage In-kind items and services $86.28 General
Category: ONCOLOGY
05/30/2022 Helsinn Healthcare SA AKYNZEO (Drug) Food and Beverage In-kind items and services $56.53 General
Category: ONCOLOGY
04/22/2022 Bayer HealthCare Pharmaceuticals Inc. Consulting Fee Cash or cash equivalent $6,032.50 General
08/08/2021 Helsinn Healthcare SA AKYNZEO (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: ONCOLOGY
04/09/2021 Helsinn Healthcare SA AKYNZEO (Drug) Consulting Fee Cash or cash equivalent $2,700.00 General
Category: ONCOLOGY
06/21/2020 Eli Lilly and Company Travel and Lodging In-kind items and services $314.88 General
05/13/2020 Helsinn Healthcare SA AKYNZEO (Drug) Consulting Fee Cash or cash equivalent $3,800.00 General
Category: ONCOLOGY
03/10/2020 Eli Lilly and Company Travel and Lodging Cash or cash equivalent $59.76 General
01/31/2020 Eli Lilly and Company Consulting Fee Cash or cash equivalent $10,500.00 General
01/26/2020 AstraZeneca Pharmaceuticals LP IMFINZI (Drug) Consulting Fee Cash or cash equivalent $685.00 General
Category: Oncology
01/20/2020 Eli Lilly and Company Travel and Lodging In-kind items and services $356.82 General
01/20/2020 Eli Lilly and Company Travel and Lodging In-kind items and services $147.00 General
01/20/2020 Eli Lilly and Company Travel and Lodging In-kind items and services $126.00 General
01/20/2020 Eli Lilly and Company Travel and Lodging In-kind items and services $69.87 General

About Dr. Richard Gralla, MD

Dr. Richard Gralla, MD is a Hematology & Oncology healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710167002.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Gralla, MD has received a total of $351,325 in payments from pharmaceutical and medical device companies, with $13,744 received in 2024. These payments were reported across 134 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($126,652).

Practice Information

  • Specialty Hematology & Oncology
  • Location New Hyde Park, NY
  • Active Since 11/05/2007
  • Last Updated 11/05/2007
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1710167002

Products in Payments

  • AKYNZEO (Drug) $132,763
  • Akynzeo (Drug) $18,001
  • NETUPITANT (Drug) $5,043
  • CINVANTI (Drug) $2,123
  • IMFINZI (Drug) $685.00
  • Stivarga (Drug) $40.44
  • TECENTRIQ (Biological) $17.09

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in New Hyde Park